The global NGS sample preparation market worth is expected to rise at a CAGR of 13.7% to USD 5441.1 Million by 2032, supported by:
Given the low cost and great efficiency of sequencing, NGS technologies have displaced conventional sequencing techniques generating higher demand for NSG sample preparation in recent years. NGS has become more affordable thanks to making the human genome accessible at only D1,000, and it is anticipated that the benefits of NGS sample preparation would increase its popularity further.
Rapid advancements in sequencing technology have increased throughput capacities significantly while also lowering costs. For instance, next-generation sequencing (NGS) costs have dropped significantly since the Human Genome Project's conclusion, according to a paper published by Illumina in the year 2021.
As a result of the aforementioned developments, it is projected that the market under study might expand exponentially throughout the course of the investigation. Nonetheless, the rigorous regulations related to NGS sample preparation and the high prices of the equipment are projected to restrain the NGS sample preparation market growth.
| Report Attribute | Details |
|---|---|
| NGS Sample Preparation Market Value (2022) | USD 1321.8 Million |
| NGS Sample Preparation Market Anticipated Forecast Value (2032) | USD 5441.1 Million |
| NGS Sample Preparation Market Projected Growth Rate (2022 to 2032) | 13.7% |
Exclusive Offer: 30% Off on Regional Reports
Get a free sample report and customize your regions for a 30% discount on your regional report!
A remarkable rise in demand for NGS sample preparation was observed during the initial phase of the Covid-19 pandemic, which pushed many countries to accept this technology and encourage capitalists to work on this domain.
There was an urgent need for diagnostic tools that may be used at lower costs and yield better findings due to the increased prevalence of Covid-19. So even during the years following the subsidence of pandemic infections, it is observed that the NGS sample preparation business is attracting more participants in order to prevent the development of new virus strains.
Over the past few years, a number of market players in the health sector entered the NGS sample preparation market, making it comparatively more fragmented than before. Later it was found that the sheer amount of regulatory compliances, technological limitations, and infrastructure insufficiency in their target regions made the whole business unfeasible.
So frequent mergers and acquisitions can be observed among the NGS sample preparation market players to get rid of the unsuccessful endeavors, and this trend is anticipated to continue for some more days ahead. For instance, Agilent Technologies purchased Resolution Bioscience in April 2021, a pioneer in the development and marketing of precision cancer solutions based on next-generation sequencing (NGS). The country's studied market is projected to develop faster as a result of these purchases.
However, the said market promises even more opportunities as CFDNA library preparation can reveal info on how to trace down numerous virus transmission pathways throughout the world and can help researchers find viral mutations that may impair the effectiveness of vaccines and the detection process.
Additionally, it is anticipated that greater support from the federal government and commercial businesses, as well as expanded use of NGS technology by state and publicly funded healthcare organizations, would propel market expansion. For example, the Broad Institute of Harvard University and DNA Script Company received nearly USD 23 Million from the Intelligence Advanced Research Projects Activity in January 2020 in the United States to provide a significant boost to businesses and clinical investigations using NGS as their foundation for innovation.
The adoption of NGS sample preparation is on a rising trajectory as Next Generation Sequencing (NGS) has evolved to be a powerful platform enabling the sequencing of thousands to millions of DNA molecules simultaneously.
In addition, the rising demand for NGS sample preparation is due to its wide range of applications including human whole genome sequencing (WGS), whole exome sequencing, targeted sequencing using panels of a few to thousands of genes, and expression profiling.
NGS has revolutionized the genome sequencing market and increasing need for personalized treatment likely drives the NGS sample preparation market growth during the forecast period.
Increase in the healthcare spending and improvement in the healthcare technology are the major factors anticipated to expand NGS sample preparation market size.
Moreover, the adoption of NGS sample preparation augments to a significant extent owing to the rise in incidence of disease conditions like cancer and use of NGS for diagnostic purpose in cancer and management or treatment of disease. As per the NGS sample preparation market report, single molecule real time sequencing is expected to be fastest growing segment due to real time preparation of samples.
Drug discovery and diagnostic application are expected be highest revenue generating and fastest growing NGS sample preparation segments, improving the overall NGS sample preparation market statistics.
Biopharmaceutical companies are biggest user of NGS samples as these companies are focusing on development of new drugs, in turn, enlarging the NGS sample preparation market share on the whole.
Increasing prevalence of genetic disorders is driving the overall demand for NGS sample preparation.
Furthermore, rising need for the personalized medicines and clinical diagnosis is expected to shape the NGS sample preparation market trends.
The NGS sample preparation market key trends & opportunities are swayed by technological advancements in sample preparation procedures and kits to standardize and simplify steps.
By transitioning from a technology used for research to one used in clinical diagnostics, NGS sample preparation market outlook is going through a significant change.
However, companies, in order to consolidate their market position by expanding the NGS sample preparation market share, must deal with issues related to library preparation and various automation techniques.
NGS is revolutionising agricultural productivity and assisting in the assessment of its impact on air, soil, gut, and water microbiomes, as well as human health, in turn, fostering the NGS sample preparation market trends and forecast.
Moreover, the adoption of NGS sample preparation is also due to the fact that NGS is also assisting in locating the origin of plant diseases and making recommendations for their eradication.
The development of veterinary medicines has been sparked by the NGS-based metagenomic screening which is considered to considerably sway the NGS sample preparation market future trends.
However, the lack of veterinary-specific protocols is hindering the NGS sample preparation market from expanding.
Consequently, players in the market are creating NGS-based protocols for veterinary virology. As a result, businesses are expanding their research into porcine samples that have been contaminated with various DNA and RNA viruses.
Molecular diagnostic tests and devices typically require more time and money to receive FDA approval.
It could be argued that delays in the introduction of new treatments pose a significant barrier to the commercialization of potentially useful tests, in turn, the overall demand for NGS sample preparation.
The European Union (EU), China, and Japan all have regulations that are similar. This negatively impacts the NGS sample preparation adoption trends, ultimately stifling the market for NGS sample preparation.
The presence of major biopharmaceutical companies and technological advancements in North America make it the most alluring region for the NGS sample preparation market.
The NGS sample preparation market share of North America is anticipated to account for 37.6% in 2022.
The significant regional market share can be primarily attributed to the encouraging initiatives by public and private organisations for the development and, the rising number of NGS-based clinical applications in the region.
Europe is anticipated to hold a NGS sample preparation market share of 23.8% in 2022 due to the focus of research institutes on development of new methods of NGS sample preparation and aging population.
There is a variation in NGS processes carried out throughout Europe, particularly the absence of bioinformatic analysis standardisation.
To benefit patients, specialised biomedical personnel with the knowledge and abilities necessary to assure the patient that testing is carried out to the highest standard throughout Europe are needed.
A small start-up by the name of SimplSeq believes that its technology will revolutionise sequencing sample preparation and ultimately displace the industry's titans.
The company is currently beta testing a technology that it claims to be faster and simpler than conventional methods and can enable better use of priceless liquid biopsy sample material. It is a spinout of a new tech incubator called Murrieta Genomics.
SimplSeq's founder and CEO, Brandon Young, is also the creator of the patented core technology. He created a technique that eliminates the need for DNA and RNA purification and uses a library.
Check Free Sample Report & Save 40%!
Select your niche segments and personalize your insights for smart savings. Cut costs now!
Some of the market participants in the global NGS sample preparation market is Thermo Fisher Scientific, Agilent Technologies, Inc., F Hoffman-La Roche AG, Illumina, Inc., Eurofins Scientific and Macrogen, Inc.
Companies in the NGS sample preparation market are utilising new opportunities in the areas of agriculture and animal research in addition to medical services to diversify their revenue sources.
In order to better understand multigenic disorders, companies in the market for NGS sample preparation are expanding their studies into the identification of novel disease genes in animals, in turn, expand the NGS sample preparation market share.
A few of the recent developments in NGS sample preparation market are as follows:
| Report Attribute | Details |
|---|---|
| Growth Rate | CAGR of 13.7% from 2022 to 2032 |
| Base Year for Estimation | 2021 |
| Historical Data | 2015 to 2021 |
| Forecast Period | 2022 to 2032 |
| Quantitative Units | Revenue in USD Million and CAGR from 2022-2032 |
| Report Coverage | Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis |
| Segments Covered |
Technology, Application, End Use, Region |
| Regions Covered |
North America; Latin America; Europe; Asia Pacific & Japan; The Middle East and Africa |
| Key Countries Profiled | USA, Canada, Brazil, Argentina, Germany, UK, France, Spain, Italy, Nordics, BENELUX, Australia & New Zealand, China, India, ASEAN, GCC, South Africa |
| Key Companies Profiled |
Thermo Fisher Scientific; Agilent Technologies, Inc.; F Hoffman-La Roche AG; Illumina, Inc.; Eurofins Scientific; Macrogen, Inc. |
| Customization | Available Upon Request |
The global NGS sample preparation market is projected to advance at a CAGR of 13.7% during the forecast period.
North America is projected to hold a NGS sample preparation market share of 37.6% in 2022.
The NGS sample preparation market is anticipated to account for USD 5441.1 million by 2032.
Explore In-vitro Diagnostics Devices Insights
View Reports
NGS Sample Preparation Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
